However, in breast cancer cells, p130cas overexpression has been shown to decrease the ability of TGF-β1 to activate Smad2/3, while depleting p130cas led to the increased activation of Smad2/3 (5). This evidence concerns the gene TGFB1 and breast carcinoma.